跳至主要内容
临床试验/TCTR20230101001
TCTR20230101001已完成不适用

Decreased levels of low-density lipoprotein cholesterol (LDL-C) in the use of low and moderate-intensity statin in type2 diabetic patients treated in community hospital.

/A0 个研究点目标入组 71 人开始时间: 2023年1月1日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
71

研究概览

简要总结

ow intensity statin can reduce LDL-C in type2 diabetic patients more than 30%, which is greater than the average percentage of LDL-C reductions according to the statin intensity according to 2013 ACC/AHA guideline. Moderately intensity statin was not different (30-50%).

研究设计

研究类型
Observational

入排标准

年龄范围
15 Years 至 100 Years(—)
性别
All

入选标准

  • 1.Type 2 diabetic patient in Bangbo hospital
  • 2. Age > 15 year olds
  • 3.LDL-C before treatment > 100 mg/dl
  • 4. Treatment of hyperlipidemia with simvastatin (10, 20, 40 mg ) or atorvastatin 20 mg
  • 5. Received at least 3 months of treatment, and LDL-C levels were monitored before and at least 3 months after dosing

排除标准

  • 1. Patients without LDL-C testing before and after drug administration
  • 2. Patients were previously treated with statins elsewhere.

研究者

发起方
/A

相似试验